Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Scilipoti

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Urologia Internationalis|November 18, 2025
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy EligibilityPietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, et al.
World Journal of Urology|March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysisAleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
Scientific Reports|June 25, 2025
Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in SwedenInnocent B Mboya, Josef Fritz, Pietro Scilipoti, et al.
BJU International|August 22, 2025
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Urologic Oncology|February 14, 2026
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathwayPietro Scilipoti, Giuseppe Rosiello, Alfonso Santangelo, et al.
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
Urologic Oncology|January 29, 2025
Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scoresMattia Longoni, Giuseppe Rosiello, Pietro Scilipoti, et al.
European Urology Oncology|June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer TrialsPietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Urologia Internationalis|November 18, 2025
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy EligibilityPietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, et al.
World Journal of Urology|March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysisAleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
Scientific Reports|June 25, 2025
Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in SwedenInnocent B Mboya, Josef Fritz, Pietro Scilipoti, et al.
BJU International|August 22, 2025
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Urologic Oncology|February 14, 2026
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathwayPietro Scilipoti, Giuseppe Rosiello, Alfonso Santangelo, et al.
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
Urologic Oncology|January 29, 2025
Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scoresMattia Longoni, Giuseppe Rosiello, Pietro Scilipoti, et al.
European Urology Oncology|June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer TrialsPietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.
Pageof 10